Direct oral anticoagulants versus vitamin K antagonists for the treatment of cerebral venous thrombosis: A systematic review and meta-analysis of randomized clinical trials [0.03%]
直接口服抗凝剂与维生素K拮抗剂治疗脑静脉血栓形成的随机对照试验的系统评价和meta分析
Maxime Delrue,Benjamin Crichi,Isabelle Crassard et al.
Maxime Delrue et al.
Background: Current guidelines consider direct oral anticoagulants (DOACs) a reasonable treatment option for cerebral venous thrombosis (CVT), but randomized evidence comparing DOACs vs. vitamin K antagonists (VKAs) remai...
Prospective comparison of viscoelastic coagulation monitor (VCM) and rotational thromboelastometry (ROTEM) in the assessment of cirrhosis coagulopathy [0.03%]
关于黏弹性凝血监测（VCM）和旋转血栓弹力图（ROTEM）在肝硬化凝血病评估中的前瞻性比较研究
Elisa Pinto,Alberto Zanetto,Elena Campello et al.
Elisa Pinto et al.
Background: Rotational thromboelastometry (ROTEM) provides comprehensive hemostasis assessment in cirrhosis but relies on exogenous activators, potentially limiting its reflection of in vivo conditions. The Viscoelastic C...
Comparative effectiveness and safety of rituximab and caplacizumab for immuno-mediated Thrombotic Thrombocytopenic Purpura: an overview of systematic reviews [0.03%]
利妥昔单抗和卡利珠单抗治疗免疫介导的血栓性血小板减少性紫癜的有效性和安全性：系统综述的综合分析
Mayra Carvalho-Ribeiro,Camila Peña,Thaís D R Nóbrega et al.
Mayra Carvalho-Ribeiro et al.
Background: Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a life-threatening disorder caused by anti-ADAMTS13 (A Disintegrin And Metalloproteinase with a ThromboSpondin type 1 motif, member 13) antibodies....
Altered IGF-1R, p70S6K, and GSK-3β expression in PBMCs of immune thrombocytopenia patients and clinical associations [0.03%]
免疫性血小板减少症患者外周血单个核细胞中IGF-1R、p70S6K和GSK-3β表达改变及其临床意义
Xin Zhou,Yuqi Shi,Yulu Liu et al.
Xin Zhou et al.
Objective: To investigate the expression profiles of insulin-like growth factor-1 receptor (IGF-1R), p70S6 kinase (p70S6K), and glycogen synthase kinase-3β (GSK-3β) in peripheral blood mononuclear cells (PBMCs) of adult...
Prevalence and clinical outcomes associated with proximal deep vein thrombosis at hospital admission detected by bedside ultrasound in patients hospitalized in a medical oncology ward: An exploratory prospective study [0.03%]
急诊超声检查在内科肿瘤病房住院患者首次查房时发现的近端深静脉血栓的患病率及临床预后：一项探索性前瞻性研究
Francisco Javier Teigell Muñoz,María García-Ferrón,María Mateos-González et al.
Francisco Javier Teigell Muñoz et al.
Background: Venous thromboembolism (VTE) is a frequent and serious complication in patients with cancer. Although lifetime VTE risk is well established, data on the prevalence of proximal deep vein thrombosis (pDVT) at ho...
Infection site modifies the prognostic impact of disseminated intravascular coagulation in sepsis [0.03%]
感染部位可改变DIC在脓毒症预后中的影响
Wataru Takayama,Natsuko Tomita,Yuhi Matsuo et al.
Wataru Takayama et al.
Background: Disseminated intravascular coagulation (DIC) is a common, life-threatening sepsis complication. Although DIC severity is widely used for risk stratification, whether its prognostic impact varies by infection s...
The perils of extrapolation: Lessons from a prospective registry of catheter-related thrombosis in patients with cancer [0.03%]
外推的危险性——癌症患者导管相关血栓形成前瞻性登记处的经验教训
Mariana Pfeferman,Gregory Piazza
Mariana Pfeferman
Postoperative thrombosis in patients with hemophilia and malignancy: Mechanisms and perioperative prevention and management - A scoping review [0.03%]
血友病和恶性肿瘤患者的术后血栓：机制及围术期预防和管理-系统综述
Lisha Zhao,Yanyan Xie,Zhenyu Yan
Lisha Zhao
Hemophilia is traditionally viewed as a hypocoagulable disorder, but the occurrence of postoperative venous thromboembolism (VTE) in these patients, particularly when malignancy is present, challenges this paradigm. Cancer-related and surge...
Outcome of catheter associated upper extremity deep vein thrombosis in cancer: A two year prospective study with enoxaparin [0.03%]
预防性使用低分子肝素对肿瘤患者置管后上肢深静脉血栓影响的前瞻性研究
Michelangelo Sartori,Alice Trentini,Sofia Cavara et al.
Michelangelo Sartori et al.
Background: Current guidelines suggest three month anticoagulation for the treatment of catheter-related upper extremity deep vein thrombosis (CRT), but few data are available on outcome beyond three months in cancer pati...
Noel C Chan,Anna M Imiela,Stephanie Carlin et al.
Noel C Chan et al.
Anticoagulant therapy has undergone a remarkable evolution over the past century, transforming the prevention and treatment of thromboembolic disease. The accidental discovery of vitamin K antagonists (VKAs) in the 1940s, following investig...